Stock 6D81 DUPONT DE NEMOURS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings DuPont de Nemours, Inc. Berne S.E.

Equities

6D81

US26614N1028

Delayed Berne S.E.
Other stock markets
 09:30:03 08/04/2024 pm IST 		5-day change 1st Jan Change
68.49 CHF -1.53% Intraday chart for DuPont de Nemours, Inc. -.--% -.--%
13/06 DuPont Launches New Tedlar® Frontsheet Offerings At 2024 Snec Pv Power Expo CI
07/06 Declaration of Voting Results by DuPont de Nemours, Inc CI

Summary

  • The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

  • The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
  • Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
  • Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
  • For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
  • The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
  • The opinion of analysts covering the stock has improved over the past four months.
  • There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.

Weaknesses

  • With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
  • The company benefits from high valuations in earnings multiples.
  • With an enterprise value anticipated at 3.16 times the sales for the current fiscal year, the company turns out to be overvalued.
  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • For the past year, analysts have significantly revised downwards their profit estimates.
  • Over the past twelve months, analysts' consensus has been significantly revised downwards.
  • The group usually releases earnings worse than estimated.

Ratings chart - Surperformance

Sector: Diversified Chemicals

1st Jan change Capi. Investor Rating ESG Refinitiv
DUPONT DE NEMOURS, INC. Stock DuPont de Nemours, Inc.
-.--% 33.75B -
SHIN-ETSU CHEMICAL CO., LTD. Stock Shin-Etsu Chemical Co., Ltd.
+3.01% 77.12B
B
BASF SE Stock BASF SE
-6.64% 43.09B
A-
PIDILITE INDUSTRIES LIMITED Stock Pidilite Industries Limited
+15.37% 19.01B
B
EASTMAN CHEMICAL COMPANY Stock Eastman Chemical Company
+9.20% 11.64B
A-
SYENSQO SA/NV Stock Syensqo SA/NV
-4.85% 9.97B -
ASAHI KASEI CORPORATION Stock Asahi Kasei Corporation
-4.04% 8.8B
A-
SRF LIMITED Stock SRF Limited
+0.78% 8.59B
C-
MITSUBISHI CHEMICAL GROUP CORPORATION Stock Mitsubishi Chemical Group Corporation
+0.01% 7.54B
B
SAHARA INTERNATIONAL PETROCHEMICAL COMPANY Stock Sahara International Petrochemical Company
-13.07% 5.64B
C+
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. DD Stock
  4. 6D81 Stock
  5. Ratings DuPont de Nemours, Inc.